Eagle Rock Energy Partners L.P. (EROC) Financials Nov 14,

New Post Public Reply Private Reply Replies (0) Message Board

Nov 14, 2014 at 9:34 PM

Eagle Rock Energy Partners L.P. (EROC) Financials Nov 14, 2014, 4:00 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Eagle Rock Energy Partners L.P.

Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 655.57M 715.23M 1.02B 923.36M 1.21B
Cost of Goods Sold (COGS) incl. D&A 604.49M 598.99M 764.8M 813.59M 1.09B
COGS excluding D&A 488.23M 490.21M 633.18M 652.55M 925.82M
Depreciation & Amortization Expense 116.26M 108.78M 131.61M 161.05M 167.17M
Depreciation 92.9M 85.9M 120.01M 149.8M 157.09M
Amortization of Intangibles 23.36M 22.88M 11.6M 11.24M 10.08M
Gross Income 51.08M 116.24M 260.16M 109.77M 120.5M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 119.38M 45.78M 55.59M 67.19M 81.11M
Research & Development 0 0 0 0 -
Other SG&A 119.38M 45.78M 55.59M 67.19M 81.11M
Other Operating Expense 8.5M 90.14M 112.2M 19.43M 20.27M
Unusual Expense 218M 68.8M (6.19M) 129.43M 233.71M
EBIT after Unusual Expense (218M) (68.8M) 6.19M (129.43M) (233.71M)
Non Operating Income/Expense 145.74M 52.4M 1.49M 5.46M 257,000
Non-Operating Interest Income 188,000 111,000 25,000 0 0
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 21.59M 15.15M 29.65M 51.48M 68.76M
Gross Interest Expense 21.59M 15.15M 29.65M 52.79M 69.73M
Interest Capitalized 0 0 0 1.31M 963,000
Pretax Income (170.46M) (51.1M) 70.42M (152.31M) (283.09M)
Income Tax 1.09M (2.55M) (2.43M) (1.7M) (5.11M)
Income Tax - Current Domestic (1.01M) (4,000) 1.15M 639,000 (105,000)
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 2.1M (1.69M) (3.59M) (2.34M) (5.01M)
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 850,000 0 - 0
Equity in Affiliates 0 0 0 - 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (171.55M) (48.56M) 72.86M (150.6M) (277.98M)
Minority Interest Expense 0 0 0 0 0
Net Income (171.55M) (48.56M) 72.86M (150.6M) (277.98M)
Extraordinaries & Discontinued Operations 290,000 43.21M 276,000 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 (718,000) 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 290,000 43.21M 994,000 0 0
Net Income After Extraordinaries (171.26M) (5.35M) 73.13M (150.6M) (277.98M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (171.55M) (48.56M) 72.86M (150.6M) (277.98M)
EPS (Basic) (2.31) - - (1.13) (1.82)
Basic Shares Outstanding 74.19M - - 135.61M 153.56M
EPS (Diluted) (2.31) - - (1.13) (1.82)
Diluted Shares Outstanding 74.19M - - 135.61M 153.56M
EBITDA 39.46M 89.11M 223.98M 184.18M 186.29M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Faith and Resilience in China: The Legacy of the Long March

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Lundbeck's Board Leadership Transitions into New Era

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Antheia Secures $80M for Critical Medicine Onshoring

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

UEG's New Advisory Board: Elevating Patient Voices

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

ASTS Faces a Legal Countdown – Investors Take Note

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Tomorrowland's Shanghai Return: An Electri-Lifesaver

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

AEVEX Faces 48-Hour Deadline for Investor Class Action

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Top 5 Most Recently Viewed Articles

Emerging Trends in Cannabis Testing Market Boost Growth

The Transforming Landscape of the Cannabis Testing Market The cannabis testing market is entering an exciting phase of development, projected to grow significantly in the coming years. The estimated expansion of USD 2.05 billion from 2024 to 2028 reflects an increasing demand intertwined with the rise of medical cannabis. With a compound annual growth rate (CAGR) of...

CeraVe's Innovative Haircare Campaign with Celebrity Stars

CeraVe Unveils Engaging Haircare Campaign CeraVe has recently launched a groundbreaking campaign titled 'Head of CeraVe', focusing on destigmatizing dandruff while raising awareness about effective scalp solutions. This timely initiative shines a light on the new Hydrating Anti-Dandruff and Gentle Hydrating haircare lines. Understanding Dandruff and Its Impact Surveys...

US Weather Forecasting System Market Expected Growth by 2029

Understanding the US Weather Forecasting System Market The US Weather Forecasting System market is on track for significant growth, anticipated to reach USD 832.2 million by 2029. This figure marks a substantial increase from USD 620.1 million in 2024, reflecting a compound annual growth rate (CAGR) of 6.1% during the forecast period. As the demand for precise weather...

Market Insights: NVIDIA's Earnings and Super Micro's Surge

Market Performance Overview As Wednesday's trading unfolded, all three major indices saw a positive uptick, marking a welcome change for investors. The S&P 500 and Nasdaq 100 aimed to break a four-day losing streak, boosted by optimism surrounding tech stocks. NVIDIA Corp.'s Earnings Announcement NVIDIA Corp. (NVDA) has emerged as a central figure within the tech sector,...

Ups and Downs: New York Community's Earnings Expectations

Upcoming Earnings Announcement for New York Community New York Community (NYSE: NYCB) is set to release its quarterly earnings report soon. This announcement has created a buzz within the investment community, as many anticipate valuable insights regarding the company's performance. Analysts' Expectations Analysts predict that New York Community will report an earnings...